Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury
Open Access
- 1 December 2016
- journal article
- Published by Elsevier in Stem Cell Reports
- Vol. 7 (6) , 1099-1115
Abstract
No abstract availableKeywords
Funding Information
- Universiteit Antwerpen
- Fonds Wetenschappelijk Onderzoek
- Agentschap voor Innovatie door Wetenschap en Technologie
This publication has 50 references indexed in Scilit:
- Interleukin-4- and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and DiseaseAnnual Review of Immunology, 2013
- Transplantation of Mesenchymal Stem Cells Promotes an Alternative Pathway of Macrophage Activation and Functional Recovery after Spinal Cord InjuryJournal of Neurotrauma, 2012
- The Fractalkine Receptor but Not CCR2 Is Present on Microglia from Embryonic Development throughout AdulthoodThe Journal of Immunology, 2012
- Immunological Variation Between Inbred Laboratory Mouse StrainsVeterinary Pathology, 2011
- Deficient CX3CR1 Signaling Promotes Recovery after Mouse Spinal Cord Injury by Limiting the Recruitment and Activation of Ly6Clo/iNOS+ MacrophagesThe Journal of Neuroscience, 2011
- Overcoming Macrophage-Mediated Axonal Dieback Following CNS InjuryJournal of Neuroscience, 2009
- Heterogeneity of Microglial Activation in the Innate Immune Response in the BrainJournal of Neuroimmune Pharmacology, 2009
- Another Barrier to Regeneration in the CNS: Activated Macrophages Induce Extensive Retraction of Dystrophic Axons through Direct Physical InteractionsThe Journal of Neuroscience, 2008
- Osteoclast differentiation and activationNature, 2003
- Alternative activation of macrophagesNature Reviews Immunology, 2003